Evidence map›Paper›PMID 29070035›Full record

ArticleBMC genomics2017

SaVanT: a web-based tool for the sample-level visualization of molecular signatures in gene expression profiles.

David Lopez, Dennis Montoya, Michael Ambrose, Larry Lam, Leah Briscoe, Claire Adams, Robert L Modlin, Matteo Pellegrini

Abstract read
In one paragraph

Article in BMC genomics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

David LopezDepartment of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, CA, 90095, USA.
Dennis MontoyaDepartment of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, CA, 90095, USA.
Michael AmbroseDepartment of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, CA, 90095, USA.
Larry LamDepartment of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, CA, 90095, USA.
Leah BriscoeDepartment of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, CA, 90095, USA.
Claire AdamsDepartment of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, CA, 90095, USA.
Robert L ModlinDivision of Dermatology, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA.
Matteo PellegriniDepartment of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, CA, 90095, USA. matteop@mcdb.ucla.edu.

Funding

UCLA SPORE in Brain CancerP50CA211015 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Fausto Rodriguez · 2017 to 2026
$25.2M
Molecular Analysis of the Host Immune Response in LeprosyR01AI022553 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ROBERT L MODLIN · 1989 to 2026
$15.7M
TCR GAMMA/DELTA LYMPHOCYTES IN HUMAN SKIN LESIONSR01AR040312 · NIAMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MODLIN, ROBERT L · 1990 to 2025
$10.4M
Vitamin D Metabolism in LeprosyP50AR063020 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MODLIN, ROBERT L · 2012 to 2016
$7.8M
Modeling granuloma formation using engineered microcapsulesR21AI121779 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MODLIN, ROBERT L, REVZIN, ALEXANDER · 2016 to 2017
$416k
NCI NIH HHS P50 CA211015NIAID NIH HHS R01 AI022553NIAID NIH HHS R21 AI121779NIAMS NIH HHS P50 AR063020NIAMS NIH HHS R01 AR040312
6 · The paper itself

Abstract

backgroundMolecular signatures are collections of genes characteristic of a particular cell type, tissue, disease, or perturbation. Signatures can also be used to interpret expression profiles generated from heterogeneous samples. Large collections of gene signatures have been previously developed and catalogued in the MSigDB database. In addition, several consortia and large-scale projects have systematically profiled broad collections of purified primary cells, molecular perturbations of cell types, and tissues from specific diseases, and the specificity and breadth of these datasets can be leveraged to create additional molecular signatures. However, to date there are few tools that allow the visualization of individual signatures across large numbers of expression profiles. Signature visualization of individual samples allows, for example, the identification of patient subcategories a priori on the basis of well-defined molecular signatures.

resultHere, we generate and compile 10,985 signatures (636 newly-generated and 10,349 previously available from MSigDB) and provide a web-based Signature Visualization Tool (SaVanT; http://newpathways.mcdb.ucla.edu/savant ), to visualize these signatures in user-generated expression data. We show that using SaVanT, immune activation signatures can distinguish patients with different types of acute infections (influenza A and bacterial pneumonia). Furthermore, SaVanT is able to identify the prominent signatures within each patient group, and identify the primary cell types underlying different leukemias (acute myeloid and acute lymphoblastic) and skin disorders.

conclusionsThe development of SaVanT facilitates large-scale analysis of gene expression profiles on a patient-level basis to identify patient subphenotypes, or potential therapeutic target pathways.

Indexed as

SoftwareAnimalsDatabases, GeneticGene Expression ProfilingGenetic Association StudiesGenomicsHumansOrgan SpecificityPhenotypeTranscriptomeUser-Computer InterfaceWeb BrowserHeterogeneous samplesMolecular signaturesTissue-specific expressionTranscriptomic analysisVisualization tools

Identifiers

PMID29070035
PMCPMC5657101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.